Skip to main content
Equibles

MARTINGALE ASSET MANAGEMENT L P

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 936944 BOSTON, MA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,127,890
+$970,273 QoQ
Shares Held
61,938
+195.9% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#76
of 183 holders
Holding Since
Sep 2022
13 quarters on record
Voting authority Sole 69% Shared 0% None 31%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. CGEM ranks #29 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,729 $21,224,776
2 INCY
Incyte Corp
 168,818 $19,137,208
3 JAZZ
Jazz Pharmaceuticals plc
 59,492 $14,335,787
4 REGN
Regeneron Pharmaceuticals, Inc.
 18,953 $11,817,953
5 LGND
Ligand Pharmaceuticals Inc
 17,562 $5,551,172
6 ACAD
Acadia Pharmaceuticals Inc
 167,893 $4,247,692
7 ALNY
Alnylam Pharmaceuticals, Inc.
 13,634 $4,104,243
8 INVA
Innoviva, Inc.
 165,115 $3,749,761

All Filings in CGEM

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,127,890 61,938
2025-06-30 $157,617 20,932
2025-03-31 $167,539 22,132
2024-12-31 $469,477 38,545
2024-09-30 $549,774 32,842
2024-06-30 $244,543 14,022
2024-03-31 $724,694 42,529
2023-12-31 $433,370 42,529
2023-09-30 $384,887 42,529
2023-06-30 $457,612 42,529
2023-03-31 $435,071 42,529
2022-12-31 $439,185 41,629
2022-09-30 $397,625 31,016